EP 2018392 A1 20090128 - PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS
Title (en)
PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS
Title (de)
PHARMAZEUTISCH UNBEDENKLICHE SALZE UND POLYMORPHE FORMEN
Title (fr)
SELS PHARMACEUTIQUEMENT ACCEPTABLES ET FORMES POLYMORPHES
Publication
Application
Priority
- GB 2007000792 W 20070306
- GB 0609465 A 20060512
Abstract (en)
[origin: WO2007132138A1] The present invention is concerned with new risedronate salts and new polymorphic forms thereof, specifically a pharmaceutically acceptable tetra-(alkali metal) salt of risedronic acid and new polymorphic forms thereof, processes of preparing the same, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.
IPC 8 full level
A61K 31/663 (2006.01); A61P 19/00 (2006.01); C07F 9/58 (2006.01)
CPC (source: EP)
A61K 31/663 (2013.01); A61P 19/00 (2017.12); C07F 9/58 (2013.01)
Citation (search report)
See references of WO 2007132138A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007132138 A1 20071122; CA 2649489 A1 20071122; EA 200870525 A1 20090428; EP 2018392 A1 20090128; GB 0609465 D0 20060621
DOCDB simple family (application)
GB 2007000792 W 20070306; CA 2649489 A 20070306; EA 200870525 A 20070306; EP 07712850 A 20070306; GB 0609465 A 20060512